No Data
No Data
Market Participants Recognise ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Revenues Pushing Shares 28% Higher
Hain Celestial Posts Upbeat Q4 Earnings, Joins Soleno Therapeutics, Energizer Holdings And Other Big Stocks Moving Higher On Tuesday
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Raises Target Price to $15
ClearPoint Neuro Price Target Raised to $15.00/Share From $11.00 by Lake Street
Lake Street Maintains Buy on ClearPoint Neuro, Raises Price Target to $15
ClearPoint Neuro Analyst Ratings
No Data
No Data